In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Kristian Wachtell; Eva Gerdts; Vittorio Palmieri; Michael H Olsen; Markku S Nieminen; Vasilios Papademetriou; Kurt Boman; Björn Dahlöf; Gerard P Aurigemma; Jens E Rokkedal; Richard B Devereux

doi:10.1097/HJH.0b013e328339f943

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Kristian Wachtell, Eva Gerdts, Vittorio Palmieri, Michael H Olsen, Markku S Nieminen, Vasilios Papademetriou, Kurt Boman, Björn Dahlöf, Gerard P Aurigemma, Jens E Rokkedal, Richard B Devereux

Department of Medicine, Glostrup

42 Citations (Scopus)

Abstract

Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.

Original language	English
Journal	Journal of Hypertension
Volume	28
Issue number	7
Pages (from-to)	1541-6
Number of pages	6
DOIs	https://doi.org/10.1097/HJH.0b013e328339f943
Publication status	Published - 1 Jul 2010

Access to Document

10.1097/HJH.0b013e328339f943

Fingerprint

Dive into the research topics of 'In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study'. Together they form a unique fingerprint.

Cite this

Wachtell, K., Gerdts, E., Palmieri, V., Olsen, M. H., Nieminen, M. S., Papademetriou, V., Boman, K., Dahlöf, B., Aurigemma, G. P., Rokkedal, J. E., & Devereux, R. B. (2010). In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. Journal of Hypertension, 28(7), 1541-6. https://doi.org/10.1097/HJH.0b013e328339f943

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. / Wachtell, Kristian; Gerdts, Eva; Palmieri, Vittorio et al.
In: Journal of Hypertension, Vol. 28, No. 7, 01.07.2010, p. 1541-6.

Research output: Contribution to journal › Journal article › Research › peer-review

Wachtell, K, Gerdts, E, Palmieri, V, Olsen, MH, Nieminen, MS, Papademetriou, V, Boman, K, Dahlöf, B, Aurigemma, GP, Rokkedal, JE & Devereux, RB 2010, 'In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study', Journal of Hypertension, vol. 28, no. 7, pp. 1541-6. https://doi.org/10.1097/HJH.0b013e328339f943

Wachtell K, Gerdts E, Palmieri V, Olsen MH, Nieminen MS, Papademetriou V et al. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. Journal of Hypertension. 2010 Jul 1;28(7):1541-6. doi: 10.1097/HJH.0b013e328339f943

@article{e587bc56cef243ebb09952aa28d07863,

title = "In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study",

abstract = "Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.",

author = "Kristian Wachtell and Eva Gerdts and Vittorio Palmieri and Olsen, \{Michael H\} and Nieminen, \{Markku S\} and Vasilios Papademetriou and Kurt Boman and Bj{\"o}rn Dahl{\"o}f and Aurigemma, \{Gerard P\} and Rokkedal, \{Jens E\} and Devereux, \{Richard B\}",

year = "2010",

month = jul,

day = "1",

doi = "10.1097/HJH.0b013e328339f943",

language = "English",

volume = "28",

pages = "1541--6",

journal = "Journal of Hypertension",

issn = "1473-5598",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

TY - JOUR

T1 - In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

AU - Wachtell, Kristian

AU - Gerdts, Eva

AU - Palmieri, Vittorio

AU - Olsen, Michael H

AU - Nieminen, Markku S

AU - Papademetriou, Vasilios

AU - Boman, Kurt

AU - Dahlöf, Björn

AU - Aurigemma, Gerard P

AU - Rokkedal, Jens E

AU - Devereux, Richard B

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.

AB - Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.

UR - https://www.scopus.com/pages/publications/77954387103

U2 - 10.1097/HJH.0b013e328339f943

DO - 10.1097/HJH.0b013e328339f943

M3 - Journal article

C2 - 20410835

SN - 1473-5598

VL - 28

SP - 1541

EP - 1546

JO - Journal of Hypertension

JF - Journal of Hypertension

IS - 7

ER -

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this